Vivozon Pharmaceutical

082800 · KOSDAQ · Health Care · SMALL CAP

Early redemption of convertible bonds (incl. overseas CBs)

Vivozon Pharmaceutical Co., Ltd. acquired US$1.76M in face value of its Series 15 private-placement convertible bonds (conversion price US$6.34/share, maturing 2028-01-31) on 2026-07-31 for US$2.03M including early-redemption interest, following the bondholder's exercise of its put option, leaving US$8.8M outstanding; the acquired bonds will be retired.

Capital raise(Early redemption of convertible bonds (incl. overseas CBs))· FILED 2026-07-31· RCEPT 20260731901334

What happened

Vivozon Pharmaceutical Co., Ltd. / Early Redemption of Convertible Bonds (incl. Overseas CBs) Before Maturity / (2026.07.31) Early Redemption of Convertible Bonds (incl. Overseas CBs) Before Maturity

Early Redemption of Convertible Bonds (incl. Overseas Convertible Bonds) Before Maturity Convertible bonds (incl. overseas CBs) Series 15

1. Matters Concerning the Bonds Acquired Before Maturity Type of bonds: Unregistered, unsecured, privately placed convertible bonds Issuance date: 2020-01-31 Issuance method: Domestic issuance (private placement) Conversion price per share (KRW): 9,000 Maturity date: 2028-01-31

2. Bond Acquisition Amount (Currency unit) 2,881,487,500 KRW: South Korean Won - Face value (electronically registered amount) of bonds acquired (Currency unit) 2,500,000,000 KRW: South Korean Won - Base exchange rate: - - Acquisition date: 2026-07-31

3. Face value (electronically registered amount) of bonds after acquisition (Currency unit): 12,500,000,000 KRW: South Korean Won

4. Reason for Acquisition Before Maturity and Future Handling Plan 1) Reason for acquisition before maturity: Redemption pursuant to the bondholder's early redemption request (put option) 2) Future handling plan: To be retired (registration cancelled) after acquisition

5. Source of Acquisition Funds: Own funds 6. Method of Bond Acquisition: Over-the-counter purchase 7. Other Matters for Reference in Investment Decisions - The bond acquisition amount includes early redemption interest.

Related Disclosures 2019-12-16 Decision to Issue Convertible Bonds (Series 15) 2019-12-17 Decision to Issue Convertible Bonds (Series 15) 2020-01-17 Decision to Issue Convertible Bonds (Series 15) 2020-01-31 Decision to Issue Convertible Bonds (Series 15) 2023-01-18 Decision to Issue Convertible Bonds (Series 15) 2026-01-23 Decision to Issue Convertible Bonds (Series 15) 2026-03-31 Early Redemption of Convertible Bonds (incl. Overseas CBs) Before Maturity (Series 15) 2026-04-30 Early Redemption of Convertible Bonds (incl. Overseas CBs) Before Maturity (Series 15)

Filed2026-07-31, Early redemption of convertible bonds (incl. overseas CBs)
SourceDART rcept 20260731901334 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-07-31 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).